📰 Anders Rylander News
Page 3 - Anders Rylander News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Anders Rylander. Real-time updates on events, politics, business and more.
May 17, 2023
UPPSALA, SE / ACCESSWIRE / May 17, 2023 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) The extra general meeting of Biovica International AB ("Biovica" or the "Company") was held today on
May 17, 2023
Biovica Signs the First Commercial Agreement for DiviTum(R) TKa in US
May 17, 2023
UPPSALA, SE / ACCESSWIRE / May 17, 2023 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica today announces that Biovica Inc, the US laboratory and subsidiary of Biovica International
April 27, 2023
UPPSALA, SE / ACCESSWIRE / April 27, 2023 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) The shareholders of Biovica International AB, reg. no. 556774-6150, (the "Company") are hereby invited
April 4, 2023
Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, today announces that the company has signed a commercial partnership agreement with the Italian company, IT Health Fusion, for the commercialization of...
April 4, 2023
UPPSALA, SE / ACCESSWIRE / April 4, 2023 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, today announces that the company has signed a commercial partnership
March 28, 2023
Biovica signs DiviTum(R) TKa Commercial Partner Agreement for Dutch ...
March 28, 2023
Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, today announces that the company has signed a commercial partnership with the European distributor TOROMEDICAL group for the commercialization of the...
March 28, 2023
UPPSALA, SWEDEN / ACCESSWIRE / March 28, 2023 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) Biovica, active in cancer monitoring, today announces that the company has signed a commercial
January 31, 2023
UPPSALA, SE / ACCESSWIRE / January 31, 2023 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II) Biovica, active in cancer diagnostics, today announces that results clinically validating the